Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

591.60 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 649
Open 591.60
Bid (Size) 593.25 (2)
Ask (Size) 593.85 (1)
Prev. Close 591.60
Today's Range 591.60 - 591.60
52wk Range 302.14 - 629.97
Shares Outstanding N/A
Dividend Yield 0.76%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?
Real-world data showed some real-world advantages for Ozempic's top rival. 
Via The Motley Fool
Eli Lilly's Options: A Look at What the Big Money is Thinking
Via Benzinga

Performance

YTD
+62.09%
+62.09%
1 Month
+4.58%
+4.58%
3 Month
+6.81%
+6.81%
6 Month
+30.33%
+30.33%
1 Year
+61.74%
+61.74%

More News

Read More
Lilly's Weight-Loss Drug Wallops Novo's In Head-To-Head Study; Novo Stock Dives
Via Investor's Business Daily
Elliott Wave Technical Analysis: Eli Lilly & Co.
Via Talk Markets
Eli Lilly's Blockbuster Mounjaro Shows Larger, Faster Weight Loss Than Novo Nordisk's Ozempic In Real World Study
Via Benzinga
Biotech And Healthcare Portfolio Playbook For December 2023/24
Via Talk Markets
$1000 Invested In Eli Lilly 10 Years Ago Would Be Worth This Much Today
Via Benzinga
The Best Stocks to Invest $5,000 in Right Now
Via The Motley Fool
Uncovering Noteworthy Technical Analysis Findings for ELI LILLY & CO (NYSE:LLY).
Via Chartmill
Novo Nordisk's Flexible Pricing Approach: Push for Broader Access, Innovative Payments
Via Benzinga
3 Top Stocks That'll Make Smart Investors Rich
Via The Motley Fool
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
Via The Motley Fool
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
Via The Motley Fool
Google Leads Five S&P 500 Stocks Near Buy Points
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Analyst Expectations for Eli Lilly's Future
Via Benzinga
A Look Into Eli Lilly Inc's Price Over Earnings
Via Benzinga
Could Ozempic Harm These 3 Medical Device Stocks?
Via The Motley Fool
$3,000 Invested in These 3 Top Stocks Could Make You Rich in 10 Years
Via The Motley Fool
Will Eli Lilly Be Worth More Than Tesla by 2027?
Via The Motley Fool
3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape
Via InvestorPlace
Eli Lilly and Novo Nordisk Are Big Names in Weight Loss, but Investors Shouldn't Count Out This Healthcare Giant
Via The Motley Fool
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
Via Benzinga
Magnificent 7 Take Center Stage In Hedge Fund Portfolios: Analysts Warn Of Extreme Concentration
Via Benzinga
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
Via Benzinga
Topics ETFs
Ignore Eli Lilly. These 2 Stocks Are Better Buys Right Now
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.